comparemela.com

Latest Breaking News On - Shionogi inc - Page 3 : comparemela.com

IDWeek 2023: Shionogi and Qpex Biopharma, Inc Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease

FLORHAM PARK, N.J., September 07, 2023 Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), announced the upcoming presentation of new data at IDWeek 2023 (October 11-15, 2023) on its investigational oral antiviral for COVID-19, ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter "ensitrelvir"), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcro

Shionogi USA: IDWeek 2023: Shionogi and Qpex Biopharma, Inc Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease

Shionogi USA: IDWeek 2023: Shionogi and Qpex Biopharma, Inc Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Glyscend Therapeutics Appoints Sapan A Shah, Ph D , Accomplished Industry Executive, as Chief Executive Officer

Glyscend Therapeutics Appoints Sapan A Shah, Ph D , Accomplished Industry Executive, as Chief Executive Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.